CarthroniX

About:

CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.

Website: https://www.carthronix.com

Top Investors: Pacira Pharmaceuticals

Description:

CarthroniX develops small-molecule-based therapies for cartilage diseases, including arthritis. They are able to preserve, repair, and regenerate cartilage in joints and simultaneously suppress inflammation.

Total Funding Amount:

$2.25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lancaster, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)carthronix.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-04-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai